This article is from the source 'bbc' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.

You can find the current article at its original source at http://www.bbc.co.uk/news/uk-politics-27339422

The article has changed 2 times. There is an RSS feed of changes available.

Version 0 Version 1
Ed Miliband made 'huge error' over Pfizer meeting says PM Miliband 'happy' to meet Pfizer boss over takeover
(about 2 hours later)
David Cameron has criticised Ed Miliband for turning down a meeting with the boss of US drug company Pfizer, accusing him of a "huge error". Ed Miliband says he would be "happy" to meet the boss of US drug company Pfizer to discuss its proposed takeover of AstraZeneca, after being criticised for previously turning down a meeting.
The Labour leader said he was too busy to meet Ian Read just days before he criticised the government's handling of Pfizer's plan to take over the UK drug company AstraZeneca. The Labour leader said he was too busy to meet Ian Read earlier this month, days before he attacked the coalition's handling of the controversial deal.
Mr Miliband said he was "happy" to have a meeting with Mr Read next week. He insisted Labour had "engaged" with Pfizer since its first offer to meet.
But the prime minister said Mr Miliband's judgement was wrong. But the prime minister said Mr Miliband had made a "huge error".
The Labour leader has accused the prime minister of being a "cheerleader" for the bid, saying assurances given by Pfizer over jobs and future research capabilities are inadequate.The Labour leader has accused the prime minister of being a "cheerleader" for the bid, saying assurances given by Pfizer over jobs and future research capabilities are inadequate.
He has called for an inquiry into whether the planned move for AstraZeneca - the biggest takeover of a UK company by a foreign firm - is in the UK's national interest.He has called for an inquiry into whether the planned move for AstraZeneca - the biggest takeover of a UK company by a foreign firm - is in the UK's national interest.
'Out campaigning''Out campaigning'
On Wednesday, the Labour leader clashed with Mr Cameron at Prime Minister's Questions over the proposed takeover. However, the BBC's Newsnight has learnt that on 28 April, after the £63bn bid was confirmed, Pfizer chief executive Ian Read wrote to the Labour requesting a meeting with him.
However, the BBC has learnt that on 28 April, after the £63bn bid was confirmed, Pfizer chief executive Ian Read wrote to the Labour requesting a meeting with him.
The Labour leader's chief of staff, Tim Livesey, wrote back the following day to say that a meeting within the next month would be "very difficult" as Mr Miliband would be too busy "out campaigning most of the time".The Labour leader's chief of staff, Tim Livesey, wrote back the following day to say that a meeting within the next month would be "very difficult" as Mr Miliband would be too busy "out campaigning most of the time".
Mr Livesey said shadow business secretary Chuka Umunna was is in discussions with Pfizer's UK chief Jonathan Emms and "we will continue to take a close interest".Mr Livesey said shadow business secretary Chuka Umunna was is in discussions with Pfizer's UK chief Jonathan Emms and "we will continue to take a close interest".
Labour sources said it was more appropriate for the shadow business secretary to take part in any talks and they are now trying to find space in Mr Miliband's diary to be able to meet with Mr Read or arrange a phone call when he is in the UK to appear in front of MPs next week . Labour sources said it was more appropriate for the shadow business secretary to take part in specific talks but they were now trying to find space in Mr Miliband's diary to be able to meet with Mr Read.
Speaking on Friday, Mr Miliband said Labour had been "engaging" with Pfizer since the deal was tabled but he had been "out on the campaign trail" earlier this month so unable to arrange a meeting.
"I am sure I will be talking to them," he said.
"I would be very happy to speak to them and I will be doing that next week."
'Specific pledges''Specific pledges'
But Mr Cameron, who has accused Labour of "playing politics" over the deal, said Mr Miliband had been wrong not to meet the Pfizer boss.But Mr Cameron, who has accused Labour of "playing politics" over the deal, said Mr Miliband had been wrong not to meet the Pfizer boss.
"The letter that the head of Pfizer wrote to me makes some specific pledges about the percentage of [research and development Pfizer] would spend in Britain," he said."The letter that the head of Pfizer wrote to me makes some specific pledges about the percentage of [research and development Pfizer] would spend in Britain," he said.
"That stands in stark contrast to the Labour leader who wouldn't even meet with him, said he was too busy. I think that was a major error of judgement.""That stands in stark contrast to the Labour leader who wouldn't even meet with him, said he was too busy. I think that was a major error of judgement."
The government has defended its handling of the issue, with Business Secretary Vince Cable insisting the government would not let Pfizer use the UK as a tax haven and promised to secure British science jobs.The government has defended its handling of the issue, with Business Secretary Vince Cable insisting the government would not let Pfizer use the UK as a tax haven and promised to secure British science jobs.
Current public-interest powers available to ministers allow them to intervene in takeover deals and mergers in a limited number of instances. These include national security concerns, media-company mergers and banks.Current public-interest powers available to ministers allow them to intervene in takeover deals and mergers in a limited number of instances. These include national security concerns, media-company mergers and banks.
They do not give ministers the scope to address concerns about jobs or investment in research and development raised by the potential Pfizer takeover.They do not give ministers the scope to address concerns about jobs or investment in research and development raised by the potential Pfizer takeover.
AstraZeneca employs more than 51,000 staff worldwide, with 6,700 in the UK. Pfizer has a global workforce of more than 70,000, with 2,500 in the UK.AstraZeneca employs more than 51,000 staff worldwide, with 6,700 in the UK. Pfizer has a global workforce of more than 70,000, with 2,500 in the UK.